203 related articles for article (PubMed ID: 15788145)
21. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
22. [Current aspects in the treatment of malignant melanoma].
Barth A; Cerny T
Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
[TBL] [Abstract][Full Text] [Related]
23. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
[TBL] [Abstract][Full Text] [Related]
24. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
25. [Vaccine strategies against melanoma].
Ghiringhelli F; Zitvogel L
Med Sci (Paris); 2006 Feb; 22(2):183-7. PubMed ID: 16457760
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
Enk AH; Becker JC; Schuler G
J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
[TBL] [Abstract][Full Text] [Related]
27. Therapy for metastatic melanoma: an overview and update.
Boyle GM
Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
[TBL] [Abstract][Full Text] [Related]
28. Treatment approaches for advanced cutaneous melanoma.
Stein JA; Brownell I
J Drugs Dermatol; 2008 Feb; 7(2):175-9. PubMed ID: 18335655
[TBL] [Abstract][Full Text] [Related]
29. [Immunotherapy in malignant melanoma].
Braathen LR; Hunger RE; Brand CU
Zentralbl Chir; 2000; 125(10):806-9. PubMed ID: 11098573
[TBL] [Abstract][Full Text] [Related]
30. Current therapy for malignant melanoma.
Legha SS
Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy of melanoma.
Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
[TBL] [Abstract][Full Text] [Related]
32. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
Hsueh EC; Morton DL
Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158
[TBL] [Abstract][Full Text] [Related]
33. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapeutic strategies for the treatment of malignant melanoma.
Alexeev V; Mucci T; Igoucheva O
G Ital Dermatol Venereol; 2008 Apr; 143(2):139-49. PubMed ID: 18833040
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell vaccines in metastasized malignant melanoma.
Erdmann M; Schuler-Thurner B
G Ital Dermatol Venereol; 2008 Aug; 143(4):235-50. PubMed ID: 18833080
[TBL] [Abstract][Full Text] [Related]
37. Possible role of adjuvant therapy for thin malignant melanoma.
Lewis GL; Tyring SK; Wagner RF
Cutis; 1992 Nov; 50(5):377-9. PubMed ID: 1468260
[TBL] [Abstract][Full Text] [Related]
38. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.
Agarwala S
Am J Clin Dermatol; 2003; 4(5):333-46. PubMed ID: 12688838
[TBL] [Abstract][Full Text] [Related]
39. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
Zigler M; Villares GJ; Lev DC; Melnikova VO; Bar-Eli M
Am J Clin Dermatol; 2008; 9(5):307-11. PubMed ID: 18717605
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of melanoma: an update.
Homsi J; Grimm JC; Hwu P
Surg Oncol Clin N Am; 2011 Jan; 20(1):145-63. PubMed ID: 21111964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
